Oxepa® Image

Oxepa®


Therapeutic Nutrition for Modulating Inflammation in Sepsis, ARDS, and ALI

  • OXEPA is clinically shown to modulate the inflammatory response in critically ill, mechanically ventilated patients, especially those with SIRS (systemic inflammatory response syndrome, eg, sepsis, trauma, burns), ALI (acute lung injury) or ARDS (acute respiratory distress syndrome).1,2,3
  • For tube feeding
  • For sole-source nutrition


References
GLA = gamma-linolenic acid (from borage oil)
* EPA = eicosapentaenoic acid (from marine oil)
1 Gadek JE, et al. Crit Care Med 1999;27(8):1409-1420.
2 Singer P, et al. Crit Care Med 2006;34(4):1033-1038.
3 Pontes-Arruda A, et al. Crit Care Med 2006;34(9):2325-2333.
4 Murray MJ, et al. Am J Physiol 1995;269 (Heart Circ Physiol 38):H2090-H2099.
5 Horrobin DF. Rev Contemp Pharmacother 1990;1:1-45.
6 Pacht ER, et al. Crit Care Med 2003;31(2):491-500.